Entia Biosciences, Inc (OTCPK:ERGO) entered into an asset purchase agreement to acquire Funguys, LLC for $0.21 million on December 17, 2013. The purchase consideration includes issue of 0.2 million shares of Entia Biosciences, waiving of $0.08 million debt owed by Noah's Nutritionals, Inc. to Entia Biosciences and a five year warrant to purchase 0.15 million shares at $0.70 per share. The transaction includes acquisition of EquiSANO, D is for Dogs, Noah's Nutritionals, and Mycella.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% |
|
-.--% | -.--% |
2017 | Entia Biosciences, Inc. Announces Management Changes | CI |
2017 | Entia Biosciences, Inc Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.41T | |
+38.65% | 3.94TCr | |
-8.62% | 3.85TCr | |
+26.95% | 3.07TCr | |
+10.74% | 2.59TCr | |
-13.50% | 2.6TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr | |
-12.61% | 1.06TCr |
- Stock Market
- Equities
- ERGO Stock
- News Entia Biosciences, Inc.
- Entia Biosciences, Inc entered into an asset purchase agreement to acquire Funguys, LLC for $0.21 million.